These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

929 related articles for article (PubMed ID: 33524423)

  • 21. Potential drawbacks of SARS-CoV-2 seroprevalence surveys.
    Lippi G
    J Hosp Infect; 2021 Apr; 110():206. PubMed ID: 33358929
    [No Abstract]   [Full Text] [Related]  

  • 22. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.
    Black JT; Haroon U; Barnes SC; Mayaleh S; Bagul A
    Transpl Int; 2021 Feb; 34(2):382-383. PubMed ID: 33320975
    [No Abstract]   [Full Text] [Related]  

  • 24. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 27. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
    Chau NVV; Toan LM; Man DNH; Thao HP; Lan NPH; Ty DTB; Hieu DK; Tien NTM; Ngoc NM; Hung LM; Dung NT; Thanh TT; Truong NT; Thwaites G; Tan LV
    J Infect; 2021 Jan; 82(1):e36-e37. PubMed ID: 33221367
    [No Abstract]   [Full Text] [Related]  

  • 30. Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
    Kinoshita R; Arashiro T; Kitamura N; Arai S; Takahashi K; Suzuki T; Suzuki M; Yoneoka D
    Emerg Infect Dis; 2023 Sep; 29(9):1868-1871. PubMed ID: 37506681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.
    Tuckerman J; Lee LY; Wurzel D; Tosif S; Clifford V; McMinn A; O'Donaghue K; Rautenbacher K; Licciardi PV; Toh R; Daley A; Crawford NW
    J Paediatr Child Health; 2021 Jul; 57(7):1136-1139. PubMed ID: 34216170
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG results among healthcare workers in a rural upstate New York hospital system.
    Brunner WM; Hirabayashi L; Krupa NL; Scribani MB; Jenkins P; Clark SD; May JJ; Gadomski AM
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1397-1400. PubMed ID: 33100252
    [No Abstract]   [Full Text] [Related]  

  • 35. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers in a surgical environment.
    De Ruyter ML; Parkulo MA; Harris DM; Hedges MS; Brinker TM; Marquez CP; Rubel NC; Simon FRL; Logvinov II; Li Z; Bosch W
    Br J Surg; 2021 Aug; 108(8):e258-e259. PubMed ID: 34151351
    [No Abstract]   [Full Text] [Related]  

  • 36. SARS-CoV-2 seroprevalence in the Vatican City State.
    Ralli M; Arcangeli A; Soave PM; Voglino MC; De-Giorgio F
    Eur J Intern Med; 2021 Apr; 86():98-99. PubMed ID: 33581980
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
    Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.
    Morikane K; Satoh N; Hatano K; Kanouchi K; Kakehata S; Satoh S; Uyeki TM; Ueno Y
    Western Pac Surveill Response J; 2021; 12(1):69-71. PubMed ID: 34094628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.